Post Exposure Prophylaxis study (treated after exposure to the virus)
et al., Medical Journal of Bakirkoy, 16:3, 280-6, doi:10.5222/BMJ.2020.50469 (Peer Reviewed)
Hydroxych loroquine Use on Healthcare Workers Exposed to COVID-19 -A Pandemic Hospital Experience
Small prophylaxis study of 208 healthcare workers in Turkey, 138 with high risk exposure received HC
Q, while 70 with low and medium risk exposure did not. COVID-19 cases were lower in the treatment group, relative risk RR 0.43, p
= 0.026. Since the control group had lower risk, the actual benefit may be larger.
COVID-19 case, ↓57.0%, p=0.03
Please send us corrections, updates, or comments.